Compare Alcon AG (ALC) vs Howmet Aerospace Inc (HWM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Howmet Aerospace Inc — how do they compare? Alcon AG trades at $66.93 (market cap $32.69B), while Howmet Aerospace Inc trades at $270.8 (market cap $110.20B). The key difference: Howmet Aerospace Inc is far larger — about 3.4× Alcon AG's market cap, and Alcon AG pays the higher dividend (0.54%). Which is the better fit depends on your goals.
| ALC | HWM | |
|---|---|---|
Market Cap | $32.69B | $110.20B |
Sector | Health | Industrials |
52-Week High | $92.22 | $283.23 |
52-Week Low | $62.02 | $171.00 |
Enterprise Value | $36.28B | $112.45B |
Dividend Yield | 0.54% | 0.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Howmet Aerospace (HWM) trades at $277.91, up 2.77% today, reflecting strong momentum in the aerospace and defense sectors. The stock exhibits bullish technical signals with support at $273 and resistance at $282. Recent earnings show mixed results, with Q1 2026 missing estimates, but robust profitability metrics like a 20.22% net margin and 33.98% ROE highlight operational strength. Positive sentiment is driven by defense demand and commercial aerospace growth, as noted in Zacks Investment Research articles from July 2026.
Outlook remains positive with an 83% analyst buy rating and a $313.50 consensus price target, suggesting 13% upside. Risks include premium valuations (P/E of 62.74) and execution challenges amid economic uncertainty. The company's cash flow growth and dividend payments support investor confidence, but high multiples warrant caution for new entries.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →
